OTCMTOBAF
Market cap587kUSD
Dec 24, Last price
0.10USD
1D
-3.18%
1Q
-46.11%
IPO
-70.94%
Name
TAAT Global Alternatives Inc
Chart & Performance
P/E
—
P/S
0.01
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
63.15%
Rev. gr., 5y
%
Revenues
95m
+122.45%
Net income
-11m
L-55.36%
CFO
-1m
L-88.67%
Earnings
Jul 14, 2025
Profile
TAAT Global Alternatives Inc., a life sciences company, develops, manufactures, and distributes non-tobacco based smokable products in Canada and the United States. It offers nicotine-free and tobacco-free alternatives to traditional cigarettes under the TAAT brand. The company was formerly known as TAAT Lifestyle & Wellness Ltd. and changed its name to TAAT Global Alternatives Inc. in April 2021. TAAT Global Alternatives Inc. was incorporated in 2006 and is headquartered in Toronto, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑10 | 2022‑10 | 2021‑10 | 2020‑10 | 2019‑10 | 2018‑10 | 2017‑10 | 2016‑10 | 2015‑10 | |
| Income | |||||||||
Revenues | 94,622 122.45% | 42,536 1,561.09% | |||||||
Cost of revenue | 96,774 | 64,974 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | (2,152) | (22,438) | |||||||
NOPBT Margin | |||||||||
Operating Taxes | 121 | 271 | |||||||
Tax Rate | |||||||||
NOPAT | (2,273) | (22,708) | |||||||
Net income | (11,117) -55.36% | (24,904) -25.68% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 1,238 | ||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | 5,973 | 3,551 | |||||||
Long-term debt | 6,197 | 8,165 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | 11,635 | 10,791 | |||||||
| Cash flow | |||||||||
Cash from operating activities | (1,064) | (9,394) | |||||||
CAPEX | (573) | (640) | |||||||
Cash from investing activities | (573) | (1,741) | |||||||
Cash from financing activities | 1,585 | 141 | |||||||
FCF | 2,055 | (28,935) | |||||||
| Balance | |||||||||
Cash | 536 | 677 | |||||||
Long term investments | 248 | ||||||||
Excess cash | |||||||||
Stockholders' equity | (111) | 8,797 | |||||||
Invested Capital | 8,639 | 16,104 | |||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | 11,090 | 10,435 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | 489 | (20,877) | |||||||
EV/EBITDA | |||||||||
Interest | 743 | 226 | |||||||
Interest/NOPBT | |||||||||